Skip to Main Content

Author Details

Johan Bussink
Radboud University, Nijmegen Medical Centre
1995
241
58
PMIDPaper TitleJournal TitlePublished Year
36755288Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer.Cancer Metab2023
37331783[18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription.Semin Radiat Oncol2023
36882391Quantitative Imaging of Hypoxic CAIX-Positive Tumor Areas with Low Immune Cell Infiltration in Syngeneic Mouse Tumor Models.Mol Pharm2023
36727633The effect of single bout and prolonged aerobic exercise on tumor hypoxia in mice.J Appl Physiol (1985)2023
35267597Segmentation Uncertainty Estimation as a Sanity Check for Image Biomarker Studies.Cancers (Basel)2022
35471557Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment.Clin Cancer Res2022
35359962PD-L1 Antibody Pharmacokinetics and Tumor Targeting in Mouse Models for Infectious Diseases.Front Immunol2022
35044182Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells.Mol Pharm2022
35070990Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy.Front Oncol2022
34904929ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer.Autophagy2022
33419779Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination Therapy.Clin Cancer Res2021
33592541Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment.Cell Immunol2021
33707312Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunity.J Immunother Cancer2021
33802339Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell Lines.Cancers (Basel)2021
34859607Secretion of pro-angiogenic extracellular vesicles during hypoxia is dependent on the autophagy-related protein GABARAPL1.J Extracell Vesicles2021
34816024A systematic review and quality of reporting checklist for repeatability and reproducibility of radiomic features.Phys Imaging Radiat Oncol2021
34667885Radiomics integration into a picture archiving and communication system.Phys Imaging Radiat Oncol2021
34485720Imaging carbonic anhydrase IX as a method for monitoring hypoxia-related radioresistance in preclinical head and neck cancer models.Phys Imaging Radiat Oncol2021
34688808Deep learning model for automatic contouring of cardiovascular substructures on radiotherapy planning CT images: Dosimetric validation and reader study based clinical acceptability testing.Radiother Oncol2021
34359379The Influence of the Exclusion of Central Necrosis on [<sup>18</sup>F]FDG PET Radiomic Analysis.Diagnostics (Basel)2021
31046897Changes in DNA Damage Repair Gene Expression and Cell Cycle Gene Expression Do Not Explain Radioresistance in Tamoxifen-Resistant Breast Cancer.Oncol Res2020
31868000Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions.Diab Vasc Dis Res2020
31804145Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO <i>in silico</i> study.Br J Radiol2020
31911366Distributed learning on 20 000+ lung cancer patients - The Personal Health Train.Radiother Oncol2020
32771614National societies' needs as assessed by the ESTRO National Societies Committee survey: A European perspective.Radiother Oncol2020
32966313Adding the temporal domain to PET radiomic features.PLoS One2020
32361013AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC.Radiother Oncol2020
32539805Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial.BMC Cancer2020
32342862Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.Radiother Oncol2020
29493265HPV, hypoxia and radiation response in head and neck cancer.Br J Radiol2019
31817870ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker.Cancers (Basel)2019
31641134Distributed radiomics as a signature validation study using the Personal Health Train infrastructure.Sci Data2019
31696402Tracers for non-invasive radionuclide imaging of immune checkpoint expression in cancer.EJNMMI Radiopharm Chem2019
31668020Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes.Thorac Cancer2019
31827111CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models.Sci Rep2019
33458432Comparison of dose metrics between automated and manual radiotherapy planning for advanced stage non-small cell lung cancer with volumetric modulated arc therapy.Phys Imaging Radiat Oncol2019
31615071The Role of Hypoxia and the Immune System in Tumor Radioresistance.Cancers (Basel)2019
31271827Inhibition of CDK4/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell Carcinomas.Int J Radiat Oncol Biol Phys2019
31271079Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer.Acta Oncol2019
31317787Downregulation of matrix Gla protein is a biomarker for tamoxifen-resistant and radioresistant breast cancer.Biomark Med2019
31624303Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts.Sci Rep2019
31417963Learning from scanners: Bias reduction and feature correction in radiomics.Clin Transl Radiat Oncol2019
30867470Deletion of hematopoietic Dectin-2 or CARD9 does not protect against atherosclerotic plaque formation in hyperlipidemic mice.Sci Rep2019
31015133Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence.Radiother Oncol2019
31011231Poor outcome in hypoxic endometrial carcinoma is related to vascular density.Br J Cancer2019
30730570Erratum: "Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers" [Med. Phys. 45 (7), 3449-3459 (2018)].Med Phys2019
30550290Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models.Mol Pharm2019
30459153PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer.Cancer Immunol Res2019
29317433Improved Evaluation of Antivascular Cancer Therapy Using Constrained Tracer-Kinetic Modeling for Multiagent Dynamic Contrast-Enhanced MRI.Cancer Res2018
33458400Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring <sup>18</sup>F-FDG-PET/CT.Phys Imaging Radiat Oncol2018
  • 1 - 50 of 241

Recommended Authors

Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Emmanouil Fokas
Universityhospital Frankfurt
Career Start Year 2007
Number of shared co-authors 2
Daniel R Gomez
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 2
Ayman Oweida
Universite de Sherbrooke
Career Start Year 2004
Number of shared co-authors 0
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 4
Ezra E W Cohen
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 2
Sana D Karam
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 1
Christopher D Willey
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
David A Palma
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 7
Eric J Sherman
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 1
Michael Bergqvist
Umea University
Career Start Year 1998
Number of shared co-authors 0
Francesca M Buffa
University of Oxford
Career Start Year 1998
Number of shared co-authors 11
Anthony J Cmelak
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 0
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year 1996
Number of shared co-authors 1
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Kevin Camphausen
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 6
Robert G Bristow
University of Toronto
Career Start Year 1989
Number of shared co-authors 9
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 5
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 5
David G Pfister
Memorial Sloan Kettering Cancer Center
Career Start Year 1987
Number of shared co-authors 1
Danielle Van den Weyngaert
University of Antwerp
Career Start Year 1987
Number of shared co-authors 4
John L Humm
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 9
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 1
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 1
Catharine M L West
University of Manchester
Career Start Year 1981
Number of shared co-authors 11
Adrian L Harris
University of Oxford
Career Start Year 1981
Number of shared co-authors 16
John P Kirkpatrick
Duke University Medical Center
Career Start Year 1978
Number of shared co-authors 1
Richard P Hill
Princess Margaret Cancer Centre
Career Start Year 1968
Number of shared co-authors 5

Collaborators

Johannes H A M Kaanders
Radboud University Medical Center
Co-authored papers 93
Paul N Span
Radboud University Medical Center
Co-authored papers 71
Albert J van der Kogel
University of Wisconsin School of Medicine and Public Health
Co-authored papers 66
Esther G C Troost
German Cancer Research Center (DKFZ)
Co-authored papers 36
Fred C G J Sweep
Radboud University Medical Centre
Co-authored papers 29
Philippe Lambin
Maastricht University
Co-authored papers 18
Bianca A W Hoeben
Radboud University Medical Center
Co-authored papers 15
Hanneke W M van Laarhoven
Cancer Center Amsterdam
Co-authored papers 12
Ludwig Dubois
Maastricht University
Co-authored papers 10
Andre Dekker
Maastricht University Medical Centre
Co-authored papers 9
Dirk De Ruysscher
Maastro Clinic
Co-authored papers 8
Cary Oberije
Maastricht University Medical Centre
Co-authored papers 6
Hugo J W L Aerts
Harvard Medical School
Co-authored papers 6
Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Co-authored papers 6
Marc Vooijs
Maastricht University Medical Centre+
Co-authored papers 6
Wouter van Elmpt
Maastricht University Medical Center+
Co-authored papers 5
Ralph T H Leijenaar
Maastricht University Medical Center (MUMC+)
Co-authored papers 5
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Co-authored papers 5
Jeroen J J P van den Beucken
Radboud University Medical Center
Co-authored papers 4
Mathieu Hatt
INSERM
Co-authored papers 3
Marianne Koritzinsky
Princess Margaret Cancer Centre University Health Network
Co-authored papers 3
Adrian C Begg
The Netherlands Cancer Institute
Co-authored papers 3
Frank J P Hoebers
Maastricht University Medical Centre
Co-authored papers 2
Coen R N Rasch
Leiden University Medical Center
Co-authored papers 2
David R Raleigh
University of California san francisco
Co-authored papers 2
Maud H W Starmans
Ontario Institute for Cancer Research
Co-authored papers 2
Vincenzo Valentini
Universita Cattolica del Sacro Cuore
Co-authored papers 2
Marike W van Gisbergen
Maastricht University
Co-authored papers 2
Natasja G Lieuwes
Maastricht University
Co-authored papers 2
Ronald Boellaard
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Co-authored papers 1
Release 1.2